WHEATON, ILL., May 10, 2016 -- Marianjoy Rehabilitation Hospital recently began construction on the new Tellabs Center for Neurorehabilitation and Neuroplasticity (TCNN), a 4,800 square-foot treatment space dedicated to providing patients access to the latest innovations in rehabilitation technology. The center is expected to open in September 2016, and will be part of the Marianjoy Assistive Rehabilitation Technology Institute located on the main hospital campus in Wheaton.
Supported by a generous grant from the Tellabs Foundation, the center will be home to the hospital's most advanced technology for patients receiving treatment following a stroke, brain injury, spinal cord injury, post-concussion syndrome and a variety of neurologic conditions.
"The creation of this new center will allow patients access to innovative physical rehabilitation delivered with the caring spirit they have come to expect from Marianjoy," said Kathleen Yosko, President of Marianjoy. "We are profoundly grateful to the Tellabs Foundation for their gift which will enable us to blend our history of 'high-touch' compassionate care with the 'high-tech' legacy of Tellabs."
The new treatment technology to be offered in the TCNN has the potential to dramatically improve outcomes for Marianjoy patients, approximately 70 percent of whom have some form of neurologic impairment. According to Dr. Jeffrey Oken, Vice President for Medical Affairs at Marianjoy, "utilizing the resources within this center, clinicians will be able to provide interdisciplinary comprehensive diagnostic and treatment services utilizing cutting-edge technology and evidence-based treatment protocols, which will optimize patient mobility and function."
The advanced treatment capabilities of the TCNN at Marianjoy will allow clinicians to begin interventions at earlier stages of recovery, promoting brain neuroplasticity – the capability of nerve cells in the brain to reorganize and reconnect to new neural pathways around damaged areas – which is a growing focus of research in the field of Physical Medicine and Rehabilitation.
Among the many new care offerings in the TCNN will be treatment utilizing the ZeroG® Gait and Balance Training System, a ceiling-mounted harness system that provides dynamic body-weight support to patients learning to walk after illness or injury. The center will also feature robotic devices including the Ekso™ GT exoskeleton and the Armeo®Power arm rehabilitation device. This equipment will be used in conjunction with traditional therapy designed to optimize patient improvement.
About Marianjoy Rehabilitation Hospital
Marianjoy Rehabilitation Hospital, part of Northwestern Medicine, is a specialty rehabilitation hospital located in Wheaton, Il. Dedicated to the delivery of Physical Medicine and Rehabilitation, Marianjoy offers specialty programs for adult and pediatric patients requiring inpatient acute, sub-acute, or outpatient rehabilitation following an illness, accident, or injury. Clinicians and therapists at Marianjoy provide individualized intensive therapy for patients seeking to regain physical function and independence. For more information, visit www.Marianjoy.org.
About the Tellabs Foundation
The Tellabs Foundation was established by Tellabs, Inc., a global telecommunications equipment provider formerly based in Naperville, Illinois. The Tellabs Foundation supports the priority areas of education, health and the environment. Since 1997, the Foundation has given more than $20 million to nonprofit organizations.
For more information about this or any of the offerings at Marianjoy Rehabilitation Hospital please contact John Brady at 630-909-7520 or via email at [email protected].
CONTACT: John Brady
Marianjoy Rehabilitation Hospital
P: 630.909.7520 | F: 630.909.7519
E: [email protected]
marianjoy.org


Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Italy Fines Apple €98.6 Million Over App Store Dominance 



